Sensyne up almost 19% as AIM IPOs continue to shine
Sensyne Health, an artificial intelligence company listed on the Alternative Investment Market in London, is trading 18.6% above its IPO price, making it the latest success for the UK mid-market IPO sector.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: